Molbio Diagnostics Ltd Quarterly Result

Molbio Diagnostics Ltd Quarterly Result

Image

Molbio Diagnostics Ltd

NSE: MOLBIO

Net Profit - Last Quarter

₹ 52.74 Cr.

Last updated on: Sep 28, 2026

null Quarterly Results Key Highlights

  • The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore.
  • This represent the decline of -27.22% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore.
  • This represent the decline of -36.59% The net profit of Molbio Diagnostics Ltd for the Jun '26 is ₹ 52.74 crore as compare to the Mar '26 net profit of ₹ 95.83 crore.
  • This represent the decline of -44.97%.

null Quarterly Results Analysis

Market Price of Molbio Diagnostics Ltd

1M

1Y

3Y

5Y

Monitoring Molbio Diagnostics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Sep 20261234.9
25 Sep 20261246.15
24 Sep 20261246.2
23 Sep 20261310.4
22 Sep 20261265.05
21 Sep 20261219.35
18 Sep 20261288.6
17 Sep 20261285.05
16 Sep 20261312.65
15 Sep 20261361.4

Historical Revenue of Molbio Diagnostics Ltd

No data available

* All values are in ₹ crore

Historical EBITDA of Molbio Diagnostics Ltd

No data available

* All values are in ₹ crore

Historical Net Profit of Molbio Diagnostics Ltd

No data available

* All values are in ₹ crore

Molbio Diagnostics Ltd News Hub

Molbio Diagnostics IPO subscribed 83%

The initial public offer of Molbio Diagnostics received bids for 67,67,496 shares as against 81,58,5

Read more

10 Aug 26

Stock Alert: Tata Motors, Mazagon Dock, Brigade Ent, RVNL, Cohance Life

Securities in F&O Ban: Shares of Inox Wind, Kaynes Technology, LIC Housing Finance and SAIL barred f

Read more

07 Sept 26

Molbio Diagnostics reports consolidated net profit of Rs 58.75 crore in the June 2026 quarter

Net profit of Molbio Diagnostics reported to Rs 58.75 crore in the quarter ended June 2026 as agains

Read more

07 Sept 26

Molbio Diagnostics IPO subscribed 70.26 times

The initial public offer of Molbio Diagnostics received bids for 57,32,14,536 shares as against 81,5

Read more

12 Aug 26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Molbio Diagnostics Ltd

  • Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
  • Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
  • The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
  • Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for Quarterly Results of null

What key financial metrics are included in Molbio Diagnostics Ltd's quarterly results?

Key financial metrics in Molbio Diagnostics Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Molbio Diagnostics Ltd announce its quarterly results?

Molbio Diagnostics Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Molbio Diagnostics Ltd's quarterly performance impact its stock price?

Molbio Diagnostics Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Molbio Diagnostics Ltd's quarterly results on dividends?

The impact of Molbio Diagnostics Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Molbio Diagnostics Ltd's quarterly results?

Yes, Molbio Diagnostics Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions